NEW IPHA RESEARCH SHOWS THAT IRELAND CONTINUES TO LAG EUROPE Ireland lags western European countries in availability of new medicines Nine medicines in the Irish reimbursement […]
The Irish Pharmaceutical Healthcare Association (IPHA), which represents the research-based pharmaceutical industry in Ireland, has announced the appointment of Mr Bernard Mallee to a new post […]
The Irish Pharmaceutical Healthcare Association (IPHA), which represents 47 research based pharmaceutical companies in Ireland has welcomed the publication of a report on Evaluating Orphan Drugs […]
IPPOSI continues its very valuable work in exploring how Ireland can perform better in making innovative medicines available to patients, according to IPHA in response to […]
BioPharma Ambition welcomes international experts to Dublin Record €67.8 billion exports for biopharmachem sector in 2017 NIBRT announces major strategic partnership in the US Dublin, […]
Ireland lags last in Western Europe – our own process needs fixing The Irish Pharmaceutical Healthcare Association (IPHA) which represents the research based pharmaceutical industry in […]
92% of people like to be involved in decisions about their own health and medication. Expanding the range of medicines available to patients and a greater […]
The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed a call from a group of organisations representing patients, healthcare professionals and the health care industry to the EU […]
BUT IRELAND IS SLOW AND LATE IN MAKING NEW CANCER MEDICINES AVAILABLE IMPROVING SPEED OF ACCESS TO NEW CANCER MEDICINES AN URGENT PRIORITY Tuesday 7th November, 2017 […]